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Depletion of CD4þ Cells Exacerbates the Cutaneous
Response to Acute and Chronic UVB Exposure
Jennifer L. Hatton1, Allison Parent2, Kathleen L. Tober1, Tyler Hoppes3, Brian C. Wulff1, F Jason Duncan3,
Donna F. Kusewitt2,4, Anne M. VanBuskirk3,4 and Tatiana M. Oberyszyn1,4
Solid organ transplant recipients have a 60–250-fold increased likelihood of developing sunlight-induced
squamous cell carcinoma (SCC) compared with the general population. This increased risk is linked to the
immunosuppressive drugs taken by these patients to modulate T cell function, thus preventing organ rejection.
To determine the importance of T cells in the development of cutaneous SCC, we examined the effects of
selectively depleting Skh-1 mice of systemic CD4þ or CD8þ T cells, using monoclonal antibodies, on ultraviolet
B (UVB) radiation-induced inflammation and tumor development. Decreases in systemic CD4þ but not CD8þ
T cells significantly increased and prolonged the acute UVB-induced cutaneous inflammatory response, as
measured by neutrophil influx, myeloperoxidase activity, and prostaglandin E2 levels. Significantly more p53
þ
keratinocytes were observed in UVB-exposed CD4-depleted than in CD4-replete mice, and this difference was
abrogated in mice depleted of neutrophils before UVB exposure. Increased acute inflammation was associated
with significantly increased tumor numbers in CD4-depleted mice chronically exposed to UVB. Furthermore,
topical treatment with the anti-inflammatory drug celecoxib significantly decreased tumor numbers in both
CD4-replete and CD4-depleted mice. Our findings suggest that CD4þ T cells play an important role in
modulating both the acute inflammatory and the chronic carcinogenic response of the skin to UVB.
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INTRODUCTION
Although less than 1–2% of the ultraviolet (UV) light from the
sun is in the 290–320 nm spectral range, UVB radiation is
responsible for the majority of cutaneous damage following
both acute and long-term exposure (Brash et al., 1991; Jung,
1991). Exposure to UV radiation induces functional changes
in both resident skin cells as well as infiltrating cells of the
immune system, which ultimately contribute to the develop-
ment of skin cancer (Elmets and Bergstresser, 1982; Kripke,
1984, 1991; Yamawaki et al., 1997). Exposure to UVB light is
initially associated with an inflammatory response characteri-
zed by increased blood flow and vascular permeability,
which results in edema and erythema, the infiltration of
neutrophils into the dermis and the induction of pro-
inflammatory cytokines and prostaglandins (Black et al.,
1978; Gilchrest et al., 1981; Jung, 1991; Rivas and Ullrich,
1994). It is now clear that inflammatory cells have significant
effects on tumor development. Early in the tumor develop-
ment process, inflammatory cells such as neutrophils can be
powerful tumor promoters. Neutrophils and other phagocytic
cells induce DNA damage in proliferating cells through the
generation of antimicrobial reactive oxygen and nitrogen
species (Dedon and Tannenbaum, 2004). In addition, these
inflammatory cells generate arachidonic acid derivatives,
including prostaglandins and leukotrienes, which exacerbate
the inflammatory response (Malech and Gallin, 1987). We
have demonstrated previously that modulating UVB-induced
prostaglandin E2 (PGE2) production via the topical applica-
tion of the COX-2-inhibitor celecoxib, inhibited both UVB-
induced acute inflammation, including neutrophil infiltration
and UVB-induced tumor development (Wilgus et al., 2000,
2003). These studies, taken together with studies carried by
others, support a link between inflammation and tumor
development in the skin and other organs (Coussens and
Werb, 2002; Clevers, 2004).
Organ and therefore patient survival following transplan-
tation have increased substantially over the past 20 years as a
result of better surgical techniques and more effective
immunosuppressive regimes. Concomitant with this in-
creased survival rate, there has been an increased incidence
of various cancers in these patients. Non-melanoma skin
cancer (NMSC) is presently the most common post-transplant
malignancy (Bavinck et al., 1993; Webb et al., 1997).
Compared with the general population, solid organ transplant
recipients have a 60–250-fold increased likelihood of
developing UVB-induced squamous cell carcinomas (SCC)
that are likely to metastasize (Hartevelt et al., 1990; Jensen
et al., 1999; Lindelof et al., 2000). In fact, SCC has been
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reported to account for 27% of deaths in Australian heart
transplant patients surviving more than 4 years after
transplantation (Ong et al., 1999). The presence of signature
mutations in the p53 gene characteristic for UV light in skin
tumors arising in immunocompromised patients indicates
that, as in the general population, UV light is also an
important etiologic factor for the development of these
tumors (McGregor et al., 1997).
The increase in skin tumor risk seen in transplant
recipients is related to the systemic immunosuppressants
these patients must take to prevent rejection of the new
organ, as lower immunosuppressant levels are correlated
with lower skin cancer incidence (Otley et al., 2001). To a
lesser extent, an increase in SCC risk also occurs in other
immunosuppressed individuals, including patients with
chronic lymphocytic leukemia (CLL), non-Hodgkin’s lym-
phoma, and HIV (Levi et al., 1996; Nguyen et al., 2002;
Hemminki et al., 2003). Multiple clinical phenomena high-
light the close relationship between cutaneous SCC risk and
immunity. For example, actinic keratoses, benign lesions that
can progress to SCC, are known to regress spontaneously in
some immunocompetent patients with prolonged photopro-
tection, presumably via immune mechanisms (Frost and
Green, 1994).
A common feature of the diseases displaying significant
increases in SCC development is suppression or dysregulation
of CD4þ T cell function. It has been reported that 23% of
transplant patients have reduced circulating levels of CD4þ
T cells (Hutchinson et al., 2003) and Ducloux et al. (1998)
reported that transplant recipients with skin cancer had
significantly lower CD4þ T cell counts compared with
transplant recipients without skin cancer. CLL patients at
increased risk for SCC have a low CD4/CD8 T-cell ratio and
severely dysregulated T-cell function (reviewed in Mellstedt
and Choudhury, 2006). A report describing recurrence of
SCC in a CLL patient on treatment with a T-cell-depressant
further supports an important connection between T cell
function and SCC risk (Davidovitz et al., 1997). Furthermore,
anecdotal evidence shows an association with CD4 leuko-
penia and Bowen’s disease (SCC in situ) (Hayashi et al.,
1997). Similarly, the progressive depletion and dysfunction
of CD4þ T cells associated with HIV infection seem likely
to explain increased risk of SCC in HIV/AIDS patients
(Wilkins et al., 2006). Thus, various primary immune defects
in T cell function occurring in disease states or following
immunosuppressive therapy may result in increased SCC
development.
In this study, we used the Skh-1 hairless mouse model of
UVB-induced inflammation and carcinogenesis to examine
the effects of CD4þ T cell depletion on the cutaneous
response to both acute and chronic UVB exposure. We used
immunohistochemical analysis and a biochemical assay to
determine changes in the levels of UVB-induced neutrophil
infiltration into the skin as one marker of changes in
inflammation. The levels of PGE2, a potent mediator of the
UVB-induced inflammatory response in the skin and a key
mediator in the development of UVB-induced skin tumors,
were also evaluated (Wilgus et al., 2000, 2003). P53
stabilization as indicated by nuclear immunoreactivity was
used as an indicator of DNA damage (Selivanova, 2002). We
report that CD4þ T cells infiltrated into the skin following
UVB exposure and that the specific depletion of CD4þ
T cells increased both the acute UVB-induced inflammatory
response, as well as the number of UVB-induced tumors.
Furthermore, topical treatment with the anti-inflammatory
drug celecoxib significantly decreased tumor numbers in
CD4þ T-cell depleted mice, supporting the link between the
enhanced inflammation seen in the immunocompromised
animals and tumor development. This study suggests that the
CD4þ lymphocyte, a cell type clearly affected by both
disease-related and therapeutic immunosuppression, has
important roles in modulating UV-induced inflammation
and protecting against UV-induced skin tumor development.
RESULTS
Cutaneous T cell infiltration following acute UVB exposure is
altered by specific T cell depletion
To examine the effect of systemic CD4 or CD8 depletion on
CD4þ and CD8þ T cell infiltration into the skin in response
to acute UVB exposure, Skh-1 hairless mice (n¼10 per
group) were injected intraperitoneally (i.p.) with anti-CD4,
anti-CD8, or IgG control antibodies. Mice were exposed to
UVB on non-consecutive days for a total of three exposures;
skin was harvested 24 hours after the last exposure. The
numbers of CD4þ or CD8þ cells were quantitated by
immunohistochemistry. As demonstrated in Figure 1a,
exposure to UVB resulted in a statistically significant
(Po0.02) increase in the number of CD4þ T cells in the
epidermis of mice injected with the control IgG antibody
compared with non-UVB-exposed IgG-injected mice. Selec-
tive depletion of CD4 cells with anti-CD4 antibodies caused
a statistically significant (Po0.04) decrease in the number of
CD4þ T cells infiltrating into the epidermis following UV
exposure. Selective depletion of CD8þ cells had no effect on
UV-induced CD4þ T cell infiltration of the skin.
As expected, selective depletion of CD8þ cells with anti-
CD8 antibodies resulted in a statistically significant
(Po0.001) decrease in the number of CD8þ T cells
infiltrating into the epidermis (Figure 1b). UVB exposure
alone did not increase CD8þ cell numbers in the epidermis.
However, selective depletion of CD4þ cells resulted in a
significant increase in CD8þ cells (Po0.0006) in the
epidermis.
UVB-induced myeloperoxidase levels are increased in skin from
CD4-depleted mice
Increased neutrophil number and activity are a hallmark of
the acute UVB-induced inflammatory response in the skin.
Myeloperoxidase (MPO) is an enzyme produced by neutro-
phils that converts hydrogen peroxide to hypochlorous
acid. MPO activity reflects the level of neutrophil activation
in tissues and is an accurate measure of cutaneous
inflammation. As we have reported previously (Wilgus
et al., 2000), exposure to UVB (UV/IgG) resulted in
a significant increase (Po0.01) in cutaneous MPO levels
as well as neutrophil numbers compared with the
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non-UVB-exposed control skin (IgG; Figure 2a–d). A sig-
nificant increase in MPO (Po0.004) as well as neutrophil
number (Po0.04) was observed in the skin of UVB-exposed
CD4-depleted animals (UV/anti-CD4) compared with control
IgG-injected UVB-exposed animals (Figure 2a–d). There was
no significant difference between MPO levels or neutrophil
numbers in the skin of CD8-depleted (UVV/anti-CD8) versus
control IgG-treated animals exposed to UVB.
We also examined the effect of CD4 depletion on MPO
levels at 24 hours, 48 hours, and 1 week following a single
exposure to UVB. As shown in Figure 2b, peak levels of MPO
were achieved in skin isolated from IgG-injected mice at
48 hours following a single UVB exposure. Selective deple-
tion of CD4þ cells not only increased MPO levels at both 24
and 48 hours compared with controls (Po0.001 and
Po0.004, respectively), but also prolonged the observed
increase in MPO levels through 1 week (Po0.005).
CD4 depletion increases cutaneous PGE2 levels and enhances
p53 induction within the epidermis in UVR-exposed skin
The effects of UVB exposure and CD4 depletion on PGE2
levels were examined following 1 week of UVB exposure.
Mice received three UVB exposures on non-consecutive days
and skin was harvested 24 hours after the last exposure.
Levels of PGE2 in UVB-exposed control IgG-injected mice
(UV/IgG) were significantly increased compared with levels
in unirradiated controls (IgG; Po0.002) (Figure 3a). Deple-
tion of CD4þ cells significantly enhanced UVB-induced
PGE2 production (Po0.006).
Immunohistochemical analysis of the skin from these mice
showed a significant increase in the number of p53þ basal
epidermal cells in the skin of UVB-exposed animals after
1 week of UVB exposure compared with non-irradiated
controls (Po0.004; Figure 3b). There was a further significant
increase in the number of p53þ cells in UVB-exposed CD4-
depleted animals (Po0.0002) compared with UVB-exposed
control IgG-injected animals. Individual p53þ epidermal
cells represented cells in which DNA damage resulting from
exposure to UVB and to local inflammatory mediators has
occurred. The p53 staining in these cells demonstrates 53
stabilization that occurs acutely in response to DNA damage.
Neutrophils contribute to increases in p53þ induction in UVB-
exposed skin
To determine the contribution of increased inflammation to
the observed increases in p53 induction in the skin of CD4-
depleted mice, Skh-1 mice (n¼5 per group) were selectively
depleted of neutrophils via injection with the neutrophil-
depleting antibody LY6G before UVB exposure. Mice
received three UVB exposures on non-consecutive days and
skin was harvested 24 hours after the last exposure. Immu-
nohistochemical analysis demonstrated a significant increase
(Po0.0006) in the numbers of dermal infiltrating neutrophils
in control animals at 1 week following UVB exposure (UV;
Figure 4a). This increase was significantly inhibited
(Po0.0008) in the skin of mice selectively depleted of
neutrophils before exposure to UVB (UV/Ly6G). P53 im-
munohistochemical analysis of the skin of these mice
demonstrated a significant increase in the number of p53þ
epidermal cells in UV-exposed skin (UV; Figure 4b;
Po0.0002). This number was significantly decreased in the
skin of mice selectively depleted of neutrophils before
exposure to UVB (Po0.003; UV/anti-Ly6G).
CD4 depletion enhances skin tumor development in response to
chronic UVB exposure
Skh-1 hairless mice (n¼ 40) were exposed to 2240 J/m2 UVB
three times weekly for 10 weeks. At week 11, selective
depletion of CD4þ cells was initiated. This treatment strategy
was designed to mimic the situation of midlife transplant
patients who have had substantial UVB exposure before
transplantation and therapeutic immunosuppression. Mice
were randomized into one of four groups (n¼10) and either
(1) injected with control IgG antibodies and treated topically
with (a)acetone (n¼ 10; UV/IgG/Ace) or (b) celecoxib
(n¼10; UV/IgG/CX) or (2) injected with the CD4-depleting
antibody and treated topically with (a) acetone (n¼ 10; UV/
anti-CD4/Ace) or (b) celecoxib (n¼10; UV/anti-CD4/CX).
Acetone or celecoxib was applied immediately following
each UVB exposure. Mice continued to be exposed to UVB
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Figure 1. UVB exposure increases epidermal infiltration of CD4þ but not
CD8þ T cells. Skh-1 hairless mice were selectively depleted of CD4þ or
CD8þ cells before UVB as described in the Materials and Methods section.
Quantitation of immunohistochemically stained sections (n¼ 10 per group)
was carried out to determine the number of epidermal infiltrating CD4þ (a) or
CD8þ (b) cells. Error bars indicate SEM. (a) *Po0.02; **Po0.04; (b)
*Po0.0006; **Po0.001.
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and topically treated three times a week for the remainder of
the study. Un-irradiated age-matched, antibody-injected
controls (n¼ 5) did not develop any tumors. Tumors greater
than 1 mm in size per mouse were counted weekly beginning
at week 14. At week 20, animals in the UVB/anti-CD4/Ace
group began to exhibit a significant increase in tumor number
compared with the UVB/IgG/Ace control group (Figure 5,
Po0.05). This increase in tumor number remained evident
until the time of killing at 25 weeks. On the basis of histologic
examination, tumors included a spectrum of papillomas and
SCC. Topical treatment with the anti-inflammatory drug
celecoxib resulted in a significant (Po0.05) decrease in the
number of tumors that developed regardless of immunosup-
pressive status in both IgG-injected control mice and CD4-
depleted mice.
DISCUSSION
In humans, the CD4þ T cell is the predominant lymphocyte
infiltrating the skin in response to UV exposure (Di Nuzzo
et al., 1998). The presence of this cell type in the skin suggests
that CD4þ T cells play a critically important role in the acute
cutaneous response to UVR. In general, it has been thought
that infiltrating T cells contribute to the acute inflammatory
response. However, to date no studies have specifically
examined the potential link between CD4þ cell function and
acute UV-induced cutaneous inflammation, characterized
by neutrophil infiltration, prostaglandin production via the
COX-2 pathway and changes in p53 levels.
This study found that systemic depletion of CD4þ T cells
resulted in a significant increase in UVB-induced cutaneous
inflammation. Changes in the skin included increased Gr-1þ
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Figure 2. Selective CD4þ cell depletion increases and prolongs UVB-induced MPO levels. The MPO assay was used to evaluate effects of CD4 and CD8
depletion on UVB-induced cutaneous inflammation (a) and to evaluate differences in the onset and length of the inflammatory response (b). Numbers of
infiltrating LY6G positive neutrophils were counted in ten 60 fields per section (c). (d) Representative photomicrographs of LY6-G staining taken at  100
magnification (bar ¼ 20mm). Error bars indicate SEM. (a) *Po0.01, **Po0.004; (b) *Po0.001, **Po0.004, ***Po0.005; (c) *Po0.02, **Po0.04.
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Figure 3. Effect of selective CD4þ cell depletion on PGE2 production and
p53 induction in response to acute UVB exposure. PGE2 levels (a) in skin
isolated from mice injected with control IgG antibody or anti-CD4 antibody
before acute UVB exposure were quantitated using an enzyme-linked
immunosorbent assay. *Po0.002; **Po0.006. (b) Graphical representation
of %p53þ cells in the epidermis of treated mice. *Po0.04; **Po0.0002.
Error bars indicate SEM.
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cell infiltration and MPO activity, longer persistence of MPO
activity, increased PGE2 levels, and increased numbers of
CD8þ cells. Gr-1þ cells are typically considered neutro-
phils, although it is important to note that a small population
of monocytes/macrophages involved in inflammation also
express an intermediate level of Gr-1 (Henderson et al.,
2003). Hematoxylin and eosin analysis indicates that the
infiltrating cells are predominantly polymorpho-mononuclear
cells (neutrophils). Indeed, segmented nuclei are present in
the Gr-1þ cells (Figure 2d). However, this does not preclude
a role for macrophages in this response. Further, although
we cannot completely rule out the contribution of Gr-
1-intermediate monocytes/macrophages, the depletion
protocol used in this study depletes Gr-1-high but not
Gr-1-intermediate cells (Miura et al., 2003). We therefore
believe that the Gr-1þ cells are predominantly neutrophils.
Although the exact mechanism by which CD4þ cell
depletion enhances the inflammatory response is not known,
we suggest the following sequence of events: UVB induces
keratinocytes to produce chemotactic factors that recruit
neutrophils and potentially macrophages. The infiltrating
neutrophils produce reactive oxygen and nitrogen intermedi-
ates and inflammatory cytokines that attract T cells. CD4þ
T cells then infiltrate the skin where they act to dampen
inflammation.
CD4 depletion also resulted in increased induction of p53
in basal epidermal cells following short-term UVR exposure.
Systemically depleting neutrophils by injecting neutrophil-
depleting antibody before UVB exposure significantly de-
creased the number of p53þ basal epidermal cells. Thus, at
least a portion of the p53 induction in our CD4-depleted
groups may result from increased neutrophil infiltration.
Increased induction of p53, evident immediately after UV
exposure, is generally thought to reflect increased DNA
damage leading to p53 stabilization in keratinocytes (re-
viewed in Melnikova and Ananthaswamy, 2005). A probable
explanation of our observations would thus be that increased
cutaneous inflammation in CD4-depleted animals led to
increased production of DNA-damaging reactive oxygen
species, resulting in increased DNA damage to keratinocytes.
However, in the skin of animals exposed to UVR for 1 week,
we were not able to detect immunohistochemically signi-
ficant differences in 8-oxo-deoxyguanosine adducts, which
result from increased reactive oxygen species production or
cyclopyrimidine dimers among the treatment groups (data not
shown).
Previous studies demonstrated a positive correlation
between increased patient survival and the presence of
lymphocytes in tumors in a variety of organs including colon,
breast, and skin (Clemente et al., 1996; Menard et al., 1997;
Naito et al., 1998). Epidemiological studies in humans have
correlated systemic immunosuppression and decreased lym-
phocyte function with increased skin cancer risk (Otley et al.,
2001). In this study we show that chronic UVB exposure
combined with selective depletion of CD4þ cells resulted in
an increased tumor burden compared with control UVB-
exposed IgG-injected animals. There were no differences in
tumor size or grade between the treatment groups. Other
murine studies have also suggested a role for CD4þ T cells in
modulating skin tumors. Using an orthotopic model Cava-
nagh and Halliday (1996) demonstrated that during the
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Figure 4. Selective depletion of neutrophils decreases UVB-induced
epidermal p53. Skin of Skh-1 hairless mice selectively depleted of neutrophils
was examined immunohistochemically and quantitated for (a) dermal
neutrophil infiltration *Po0.0006, **Po0.0008; and (b) p53þ epidermal
cells. *Po0.0002; **Po0.003. Error bars indicate SEM.
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Figure 5. Effect of CD4þ cell depletion on UVB-induced tumor
development. Mice were exposed to 2240 J/m2 UVB three times weekly for
25 weeks. Beginning at week 11, mice were either injected with anti-CD4
antibodies (n¼20) or control IgG antibodies (n¼20) every 3 weeks. Half of
the mice in each group were treated topically with 0.2 ml acetone or 0.2 ml
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indicate SEM.
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development of murine UV-induced skin tumors, dendritic
epidermal T-cell inhibition of CD4þ T-cell activation played
a role in the tumor escaping immune-mediated destruction.
Moreover, CD4þ T cells are important in inducing regression
of both actinic keratotic lesions (SCC precursors) and
orthotopic SCC (Halliday et al., 1995; Patel et al., 1995;
Kondo et al., 2002; Byrne and Halliday, 2003).
There is a strong link between inflammation and
carcinogenesis. Normally, inflammation is an essential and
self-limiting homeostatic mechanism. However, dysregula-
tion of the inflammatory response can actually augment
tumor formation. Epidemiological as well as basic research
studies have demonstrated that the inflammatory response
seen following both brief periods of high intensity sun
exposure as well as chronic sun exposure plays a critical
role in the formation of NMSC (Marks et al., 1990; Gallagher
et al., 1995). Thus, it is possible that depletion of CD4þ
T cells and the subsequent increase in cutaneous inflamma-
tion that we observed in response to UVB may have modified
the subsequent development of skin cancer. In our studies,
topical treatment with the anti-inflammatory drug celecoxib
significantly inhibited tumor development supporting the
hypothesis that increased levels of inflammation in the skin
contributed to the increased tumor number seen in our
studies.
We have demonstrated that specific depletion of CD4þ
lymphocytes enhances susceptibility to UVB-induced SCC in
a murine model of UVB-induced NMSC. Both increased
UVB-induced cutaneous inflammation and decreased tumor
immunosurveillance may contribute to enhanced skin tumor
development in CD4-depleted mice. A question not ad-
dressed by this study is the potential contribution of different
CD4þ cell subpopulations to the effects we observed. As we
depleted all CD4þ cells, the exact cell responsible for the
increase in UVB-mediated inflammation and tumor number
has not yet been clarified. However, this study suggests an
important and unexpected role for CD4þ cells in maintaining
cutaneous homeostasis and modulating inflammation. Inter-
estingly, our data indicate that although normally CD8þ cells
do not infiltrate the epidermis in large numbers in response to
UVB, their numbers are significantly increased in the absence
of CD4þ cells. This suggests that a balance between the two
cells types may be necessary to regulate cutaneous inflam-
mation. A clearer understanding of the effects of immuno-
suppression on the cutaneous inflammatory response and on
skin cancer initiation, growth, and transformation into SCC
would benefit not only immunocompromised patients but the
general population as well.
MATERIALS AND METHODS
Animals
Outbred female Skh-1 hairless mice (6–8 weeks, 26–28 g, Charles
River, Wilmington, MA) were housed in the vivarium at The Ohio
State University according to the requirements established by the
American Association for Accreditation of Laboratory Animal Care.
The appropriate Institutional Animal Care Utilization Committee
approved all procedures before beginning the study. Mice were
housed on a 12-hour light/dark cycle and allowed RO water with
Baytril 100 (Bayer, Shawnee Mission, KS) at a 40–50 mg/kg dose
Baytril per mouse per day and standard lab chow ad libitum.
Acute UVB exposure and CD4þ /CD8þ cell depletion
For the acute 1 week study, CD4-depleted (n¼ 10), CD8-depleted
(n¼ 10), and IgG-control mice (n¼ 10) were exposed on three non-
consecutive days dorsally to one minimal erythemic dose (1 MED) of
UVB (2240 J/m2 as determined by a UVR meter (UVP Inc., Upland,
CA) emitted by Phillips FS40UVB bulbs (American Ultraviolet
Company, Lebanon, IN) that were fitted with Kodacell filters
(Eastman Kodak, Rochester, NY) to ensure the removal of UVC
wavelengths (290–320 nm). The GK1.5 monoclonal antibody (anti-
CD4; Ligocyte Pharmaceuticals, Bozeman, MT) was used to deplete
CD4þ cells selectively. The YTS169 monoclonal antibody (Qin
et al., 1990) (anti-CD8, used with permission from Dr. H. Waldman,
prepared by Ligocyte Pharmaceuticals) was used to selectively
deplete CD8þ cells. GK1.5 was injected i.p. in two doses of 0.5 mg/
mouse 2 days apart, with the last injection being 24 hours before
UVB irradiation, based on previous work using the GK1.5 antibody
(Orosz et al., 1997). YTS169 was injected i.p. in three doses of
0.1 mg/mouse on days 3, 2, and 0, with day 0 being the first day
of UVB irradiation, based on published work using this antibody
(Kish et al., 2005). Control rat IgG (Sigma-Aldrich, St Louis, MO) was
injected i.p. in two doses of 0.5 mg/mouse 2 days apart, with the last
injection being 24 hours before UVB irradiation. The level of
systemic CD4þ and CD8þ cell depletion per mouse was monitored
by flow cytometry. The depletion protocols were sufficient to deplete
495% of the circulating CD4þ or CD8þ T cells for at least 2 weeks
(data not shown). The antibodies and isotypic controls used to stain
the cells for flow cytometry were CD3-FITC, CD4-PE, CD8-Cy-
Chrome, FITC-rat IgG2bk isotype control, PE-rat IgG2bk isotype
control and Cy-Chrome-rat IgG2ak isotype control (Pharmingen, BD
Biosciences, San Diego, CA). The animals were killed 24 hours after
their last UVB exposure.
Chronic UVB exposure and CD4þ cell depletion
For the chronic study, 40 animals were exposed to 1 MED of UVB on
three non-consecutive days per week for 25 weeks, then divided into
injection groups. At the beginning of week 11, animals were
randomized and injected with either CD4-depleting antibody
(n¼ 20) or control IgG (n¼ 20) as follows: Skh-1 hairless mice were
injected with GK1.5 or control rat IgG i.p. in two doses of 0.5 mg/
mouse 2 days apart every 3 weeks. To determine the systemic level
of T lymphocyte depletion, white blood cells from each animal were
isolated from peripheral blood collected by retro-orbital bleeding
before the first T-cell-depleting antibody injection, every 6 weeks
during the chronic study and at the time of killing. The antibodies
and correct isotypic controls used to stain the cells for flow
cytometry were CD3-FITC, CD4-PE, FITC-rat IgG2bk isotype
control, and PE-rat IgG2bk isotype control (Pharmingen). Half
of the mice in each injection group were treated topically
immediately following UVB exposure with 0.2 ml of either the
vehicle, high-pressure liquid chromatography grade acetone (Sigma-
Aldrich), or 0.5 mg Celecoxib (Pfizer, New York, NY) dissolved in
0.2 ml acetone. To track changes in tumor number and size, tumors
larger than 1 mm were measured weekly, using digital calipers,
by an observer blinded to the experimental groups beginning at
14 weeks.
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Acute UVB exposure and LY6-G depletion
Neutrophils were depleted via i.p. injection of the Gr-1 (anti-Ly6G)
antibody, a kind gift of Dr R Fairchild (Cleveland Clinic Foundation).
Anti-Ly6G antibody was diluted in phosphate-buffered saline (PBS)
and injected i.p. 100mg/mouse (n¼ 6) on days 1, þ 1, þ 3, þ 5,
with day 0 being the day the animals were first exposed to UVB.
Control mice (n¼ 6) received antibody injection with no UVB
exposure. Mice were exposed for 1 week on three non-consecutive
days to 2240 J/m2 UVB and killed 24 hours following the last UVB
exposure.
MPO Assay
MPO activity was assessed as described previously (Tober et al.,
2006). Briefly, a 10-mm2 section of dorsal skin tissue was collected
in 0.5% hexadecyltrimethylammonium bromide (Sigma) in 50 mM
phosphate buffer. Tissues were homogenized and sequentially
sonicated, frozen in liquid nitrogen, and thawed three times. The
samples were centrifuged and the supernatants were collected.
About 290 ml of o-dianisidine dihydrochloride at 0.167 mg/ml
(Sigma) and 0.0005% hydrogen peroxide in phosphate buffer was
added to 10 ml supernatant of each sample. MPO activity was
measured over a 5 minutes period at 450 nm with a programmable
microplate reader (Molecular Devices, Menlo Park, CA). The data
are expressed as mean units of MPO activity per experimental group.
PGE2 EIA
A 10-mm2 section of dorsal skin tissue from each mouse was
collected and snap-frozen. Tissues were homogenized in 1 ml of
protein homogenation buffer (60 mM Tris-HCl, 5 mM ethylene glycol
bis(aˆ-aminoethylether)-N,N,N’,N’,-tetraacetic acid, 5 mM ethylene-
diaminetetraacetic acid, 300 mM sucrose, 5 mM dithiothreitol,
200mg/ml leupeptin, 2 mM phenylmethylsulfonyl fluoride, 20 mg/ml
aprotinin, 10 mM sodium molybdate, 10 mM indomethacin), soni-
cated, and centrifuged. The supernatants were collected and protein
was quantitated by Bradford assay (BioRad, Hercules, CA).
A Caymen PGE2 enzyme immunoassay (EIA) (Cayman Chemical,
Ann Arbor, MI) was used to determine the concentrations of PGE2.
Eight micrograms of total protein was used for the EIA that was
performed as outlined in the manufacturer’s protocols.
Immunohistochemical analysis of CD4þ and CD8þ cells in the
skin
Frozen sections of skin were used for immunohistochemical
localization of CD4þ or CD8þ cells to verify whether the decrease
in peripheral blood also occurred in the skin. Immediately following
killing, skin sections (0.5 cm2) were placed in Tissue-Tek OCT
compound (Sakura Finetek, Torrance, CA) and stored at 801C.
Tissue sections (10 mm) were cut and mounted onto Superfrost Plus
microscope slides (Fisher Scientific, Pittsburgh, PA). The slides were
air-dried for 30 minutes at room temperature, fixed in cold acetone
for 10 minutes, and air-dried again. The sections were rinsed in Tris-
buffered saline Tween-20 (TBST) for 5 minutes (TBST: 30.8 ml of 5 M
NaCl, 100 ml Tris (pH 7.5), 1 ml Tween-20, final volume of 1 l). The
sections were blocked for endogenous peroxidases using DAKO
peroxidase block (DakoCytomation, Carpinteria, CA) for 5 minutes,
rinsed with dH2O and TBST. An avidin-biotin block (Vector
Laboratories, Burlingame, CA) was used as directed and the sections
were rinsed with TBST. DAKO Serum-free Protein Block (DakoCy-
tomation) was added for 10 minutes. Purified anti-mouse CD4 (L3T4
Clone RM4-5 from Pharmingen) or purified anti-mouse CD8a (Ly-2
Clone 53-6.7 from Pharmingen) was added at 1:20,000 (CD4) or
1:15,000 (CD8) in DAKO Ab diluent (DakoCytomation) and
incubated overnight at 41C in a humid chamber. The sections were
rinsed with TBST and biotinylated rabbit anti-rat IgG (Vector
Laboratories) was applied at 1:200 (Vector Laboratories) for
30 minutes at room temperature. The sections were rinsed with
TBST, ABC Elite was added (Vector Laboratories) for 1 hour at room
temperature and the slides were rinsed with TBST, then Millipore
water. Diaminobenzidine (DAB) (DakoCytomation) was added to
each slide for 5 minutes. The sections were rinsed with Millipore
water, methyl green (Vector Laboratories) was added for 5 minutes,
and the sections were rinsed in 95% ethyl alcohol, dehydrated, and
coverslipped. The positive epidermal cells (in or touching the
epidermis and not located in the hair follicle) in ten  60 fields per
section were determined using a Nikon microscope. The averages
used in the graph were the averages of each experimental group
(n¼ 10), with the SE.
Immunohistochemical detection of Ly6-G
Immediately following sacrifice, skin sections (0.5 cm2) were placed
in 10% neutral-buffered formalin for 2 hours, washed with PBS,
processed, and embedded in paraffin blocks. Tissue sections (5 mm)
from paraffin blocks were cut and mounted onto Superfrost Plus
microscope slides (Fisher Scientific, Pittsburgh, PA). The tissue
sections were then deparaffinized using Clear-Rite 3 (Richard-Allan
Scientific, Kalamazoo, MI) and rehydrated in a graded series of
alcohols. Following rehydration, tissues were rinsed in automation
buffer (Biomeda, Foster City, CA) and blocked with casein (Vector
Laboratories) for 30 minutes. After every step that followed, slides
were rinsed in automation buffer. The tissue was incubated with a
1:400 dilution of monoclonal rat anti-mouse Ly-6G (Pharmingen) or
appropriate isotypic control antibody overnight at 41C. The tissue
was washed and incubated with a 1:400 dilution of biotinylated
rabbit anti-rat secondary antibody (Vector Laboratories) for 30 min-
utes at room temperature, followed by an avidin/biotinylated
horseradish peroxidase complex (ABC Elite, Vector Laboratories)
for 30 minutes at room temperature. The tissue was incubated with
DAB (Vector Laboratories) for 5 minutes, rinsed with distilled water
and counterstained with hematoxylin 2 (Richard Allan Scientific,
Kalamazoo, MI) for 0.5 minute. The sections were then dehydrated,
mounted, viewed, and photographed. The numbers of Ly6G-positive
dermal neutrophils in 10  60 fields per section per mouse (n¼ 10)
were counted. The averages per experimental group were graphed
with SE.
Immunohistochemical detection of p53 protein
Immediately following sacrifice, skin sections (0.5 cm2) were placed
in 10% neutral-buffered formalin for 2 hours, washed with PBS,
processed, and embedded in paraffin blocks. Tissue sections (5 mm)
were cut and mounted onto Superfrost Plus microscope slides (Fisher
Scientific). The tissue sections were then deparaffinized using Clear-
Rite 3 (Richard-Allan Scientific) and rehydrated in a graded series of
alcohols. Following rehydration, an antigen retrieval process was
performed by placing the slides in 951C antigen-unmasking fluid for
20 minutes (Vector Laboratories) followed with a 20-minute cooling
period. The sections were washed in automation buffer (Biomeda
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Corp., Burlingame, CA) and blocked with casein for 30 minutes
(Vector Laboratories). The tissue was incubated with primary
polyclonal rabbit anti-mouse p53 antibody (Vector Laboratories)
diluted 1:300 in casein or rabbit IgG for 90 minutes at room
temperature. The tissue was washed with automation buffer, then
incubated for 30 minutes at room temperature with rabbit link
solution for 30 minutes (BioGenex, San Ramon, CA) and then label
solution for 30 minutes (BioGenex). After incubation with DAB for
6 minutes and a final wash in distilled water, the tissue was
counterstained with hematoxylin, dehydrated and mounted. The
number of p53þ basal epidermal cells in ten  60 fields per section
was determined using a Nikon Eclipse E400 inverted microscope
with a DXM1200 digital camera.
Statistical Analysis
A biostatistician was consulted for appropriate numbers of animals
per experimental group. Student’s t-test was used to study the main
effect of each treatment factor on each response measured, where
Pp0.05 is significant.
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